Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H10N2O |
| Molecular Weight | 186.2099 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC(=CC=C1)N2C=CC=CC2=O
InChI
InChIKey=ZVSGUZQJNXHNIL-UHFFFAOYSA-N
InChI=1S/C11H10N2O/c12-9-4-3-5-10(8-9)13-7-2-1-6-11(13)14/h1-8H,12H2
| Molecular Formula | C11H10N2O |
| Molecular Weight | 186.2099 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Amphenidone is a sedative and hypnotic drug. Aminophenidone was launched as Dornwal in April 1960 through a retail division of Wallace & Tiernan called Maltbie Laboratories. Amphenidone was a mild to moderate and safe antianxiety and antitension substance and suited
mainly for neurotic anxiety reaction. Amphenidone has also been shown to have antithyroid activity.
Approval Year
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Rats: The amphenidone was suspended in 0.5 per cent gelatin and administered every twelve hours by stomach tube in
a total daily dose of 0.6 or 1.0 mg per g of body weight. https://www.ncbi.nlm.nih.gov/pubmed/14038388
Anxiety and tension: Ampheidone was administered orally to 40 patients, with an
average daily dose of 3700 mg (maximum
6400 mg, minimum 1600 mg) for an average period of 3 weeks. T
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:54:52 GMT 2025
by
admin
on
Mon Mar 31 17:54:52 GMT 2025
|
| Record UNII |
M61FM2VCSV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2104057
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
134-37-2
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
M61FM2VCSV
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
8641
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
DTXSID50158449
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
SUB05484MIG
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
194
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
100000086933
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
m48
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
928
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY | |||
|
C76934
Created by
admin on Mon Mar 31 17:54:52 GMT 2025 , Edited by admin on Mon Mar 31 17:54:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
